Related Experiment Video

Updated: Sep 26, 2026

Assessment of the Metabolic Profile of Primary Leukemia Cells
06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

Commentary: effect of flavonoids on normal and leukemic cells

Stefan Faderl1, Zeev Estrov

  • 1Department of Leukemia, The University of Texas MD Anderson Cancer Center, PO Box 428, 1515 Holcombe Blvd, Houston, TX 77030, USA. sfaderl@mdanderson.org

Leukemia Research
|March 22, 2003
PubMed

Insights

Flavonoids show antiproliferative and proapoptotic effects in leukemic cells, offering potential new cancer therapies. This research highlights flavonoids as promising candidates for leukemia treatment development.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • The success of targeted therapies like imatinib mesylate underscores the importance of understanding cancer cell signaling.
  • Identifying novel molecular targets in cancer pathways is crucial for developing new therapeutic strategies.
  • Flavonoids are known inhibitors of cyclin-dependent kinases and angiogenic mediators, with emerging roles in apoptosis induction.

Discussion:

  • This study investigates the antiproliferative and proapoptotic effects of flavonoids specifically in leukemic cells.
  • The findings suggest that flavonoids can disrupt key processes in leukemia cell growth and survival.
  • Mechanisms underlying flavonoid-induced apoptosis in leukemia require further elucidation.

Key Insights:

  • Flavonoids exhibit significant antiproliferative activity against leukemia cells.
  • Flavonoids induce apoptosis in leukemic cells, suggesting a proapoptotic role.
  • These findings support the potential of flavonoids as a therapeutic class for leukemia.

Outlook:

  • Further research is warranted to fully understand the mechanisms of action of flavonoids in leukemia.
  • Clinical development of flavonoid-based therapies for leukemia may be a promising future direction.
  • Exploring specific flavonoid compounds and their synergistic effects could enhance therapeutic efficacy.

More Related Videos

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers10:49

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers

Published on: September 26, 2019

Modeling Chemotherapy Resistant Leukemia In Vitro08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...